Accurate CPT coding in gynecologic procedures ensures compliance, prevents denials, and supports proper reimbursement. CPT 57454 describes a colposcopy of the cervix and upper/adjacent vagina with biopsy and endocervical curettage (ECC). It is commonly performed after abnormal Pap smear or HPV test results to evaluate and sample cervical or vaginal lesions.
This 2025 coding guide outlines CPT 57454 based on the latest AAPC and CMS standards, including when to report it, documentation requirements, modifier usage, and reimbursement insights for OBGYN providers.
CPT 57454 – Description
Official Definition: “Colposcopy of the cervix, including upper/adjacent vagina, with biopsy(s) of the cervix and endocervical curettage.”
This code covers a diagnostic and minor therapeutic procedure performed under colposcopic visualization. It includes:
- Magnified examination of the cervix and upper vagina.
- Targeted cervical biopsy or biopsies.
- Endocervical curettage (ECC) to sample the endocervical canal.
It is more extensive than a simple colposcopy with ECC (CPT 57456) and less extensive than a loop excision or cone biopsy (CPT 57522).
When to Use CPT 57454
Use CPT 57454 when a colposcopic examination is performed and both a cervical biopsy and endocervical curettage are completed in the same session.
Common clinical indications:
- Abnormal Pap smear (ASC-H, HSIL, LSIL, AGC, etc.)
- Positive HPV test for high-risk types.
- Visualization of suspicious cervical or vaginal lesions.
- Post-treatment surveillance for cervical dysplasia.
- Unexplained postcoital or intermenstrual bleeding with abnormal cervical findings.
Do not report 57454 when:
- Only ECC is performed (use 57505).
- Only a biopsy under colposcopy is done without ECC (57454 requires both).
- Loop excision or conization is performed (use 57522).
Coding Guidelines
Per CMS 2025 global surgical rules, CPT 57454 includes:
- Cervical and vaginal inspection under colposcopy.
- Targeted biopsy collection.
- Endocervical curettage (ECC).
It has a 10-day global period (minor procedure) and should not be reported separately for ECC or simple colposcopy.
If multiple biopsies are performed, they are included within a single CPT 57454 charge — do not bill multiple units.
If the colposcopy is extended to include the vulva, use CPT 57452 in addition only if medically necessary and properly documented as a distinct service (typically with modifier 59).
Reimbursement Information
Medicare and Commercial Payers (2025):
- Average physician reimbursement: ~$140–$180 (depending on region).
- Site of service: Outpatient or office setting.
- Global period: 10 days.
- Multiple procedure reduction: Not typically applicable.
For Medicare patients, CPT 57454 is subject to standard ASC and office-based reimbursement rules. Payers may require specific diagnosis codes (ICD-10-CM) that justify medical necessity, such as N87.0–N87.9 (Cervical dysplasia), R87.610–R87.619 (Abnormal Pap test), or A63.0 (HPV-related lesions).
Always verify payer-specific LCDs (Local Coverage Determinations) or medical policies before billing.
Applicable Modifiers
Use appropriate modifiers to define procedural context and responsibility:
- Modifier 25: If performed during the same session as an unrelated E/M service.
- Modifier 59 (or XU): If an additional colposcopic site (e.g., vulva) is evaluated separately.
- Modifier 51: For multiple procedures in one session (if applicable).
- Modifier 26 / TC: Only if the provider bills separately for professional or technical components (rare in office settings).
Avoid modifier use unless supported by clinical documentation.
Documentation Requirements
Detailed documentation supports medical necessity and accurate coding. The provider’s note must include:
- Indication for colposcopy (abnormal Pap, positive HPV, visible lesion, etc.).
- Colposcopic findings: acetowhite areas, mosaicism, punctation, vascular changes.
- Location and number of biopsies taken.
- Endocervical curettage (ECC) was performed, and findings were noted.
- Pathology specimens were labeled and sent for analysis.
- Patient counseling and follow-up recommendations.
Ensure operative or procedure notes clearly reflect that both biopsy and ECC were completed.
Example Scenarios
Scenario 1:
A patient presents after an abnormal Pap smear (HSIL). The OBGYN performs a colposcopic exam, takes targeted cervical biopsies, and performs ECC. → Report CPT 57454.
Scenario 2:
Colposcopy performed for an abnormal Pap test, biopsy taken, but ECC omitted. → Report CPT 57454 is not appropriate; use CPT 57454 only when ECC is performed.
Scenario 3:
During an established visit, an abnormal lesion is identified, and the physician performs colposcopy with biopsy and ECC during the same encounter. → Report 57454 + Modifier 25 for the E/M service.
BillingFreedom – Trusted Experts in OBGYN Medical Billing and Compliance
BillingFreedom brings extensive experience in OBGYN medical billing, ensuring the accurate application of complex procedural codes, such as CPT 57454. Our certified coding specialists adhere strictly to AAPC and CMS 2025 guidelines, thoroughly reviewing documentation for completeness and compliance before submitting claims.
By focusing on precision coding, denial prevention, and payer-specific documentation standards, BillingFreedom supports OBGYN providers in achieving accurate reimbursements and maintaining audit readiness. Our expertise helps practices navigate evolving compliance requirements without interrupting patient care or workflow.
For more details about our exceptional OBGYN medical billing services, please don't hesitate to contact us via email at info@billingfreedom.com or call us at +1 (855) 415-3472.
Your financial tranquility is our priority!
Related ICD-10-CM Codes
ICD-10-CM Codes
A56.02 - Chlamydial vulvovaginitis
A60.04 - Herpesviral vulvovaginitis
A63.0 - Anogenital (venereal) warts
C52 - Malignant neoplasm of vagina
C53.0 - Malignant neoplasm of endocervix
C53.1 - Malignant neoplasm of exocervix
C53.8 - Malignant neoplasm of overlapping sites of cervix uteri
C53.9 - Malignant neoplasm of cervix uteri, unspecified
C54.0 - Malignant neoplasm of isthmus uteri
C54.1 - Malignant neoplasm of endometrium
C54.2 - Malignant neoplasm of myometrium
C54.3 - Malignant neoplasm of fundus uteri
C54.8 - Malignant neoplasm of overlapping sites of corpus uteri
C54.9 - Malignant neoplasm of corpus uteri, unspecified
D06.0 - Carcinoma in situ of endocervix
D06.1 - Carcinoma in situ of exocervix
D06.7 - Carcinoma in situ of other parts of cervix
D06.9 - Carcinoma in situ of cervix, unspecified
D07.1 - Carcinoma in situ of vulva
D07.2 - Carcinoma in situ of vagina
D26.0 - Other benign neoplasm of cervix uteri
D28.1 - Benign neoplasm of vagina
D39.0 - Neoplasm of uncertain behavior of uterus
D39.8 - Neoplasm of uncertain behavior of other specified female genital organs
N72 - Inflammatory disease of cervix uteri
N75.0 - Cyst of Bartholin's gland
N75.1 - Abscess of Bartholin's gland
N75.8 - Other diseases of Bartholin's gland
N75.9 - Disease of Bartholin's gland, unspecified
N76.0 - Acute vaginitis
N76.1 - Subacute and chronic vaginitis
N76.5 - Ulceration of vagina
N76.81 - Mucositis (ulcerative) of vagina and vulva
N76.89 - Other specified inflammation of vagina and vulva
N77.1 - Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
N80.40 - Endometriosis of rectovaginal septum, unspecified involvement of vagina
N80.41 - Endometriosis of rectovaginal septum without involvement of vagina
N80.42 - Endometriosis of rectovaginal septum with involvement of vagina
N84.1 - Polyp of cervix uteri
N84.2 - Polyp of vagina
N86 - Erosion and ectropion of cervix uteri
N87.0 - Mild cervical dysplasia
N87.1 - Moderate cervical dysplasia
N87.9 - Dysplasia of cervix uteri, unspecified
N88.0 - Leukoplakia of cervix uteri
N88.1 - Old laceration of cervix uteri
N88.2 - Stricture and stenosis of cervix uteri
N88.3 - Incompetence of cervix uteri
N88.4 - Hypertrophic elongation of cervix uteri
N88.8 - Other specified noninflammatory disorders of cervix uteri
N88.9 - Noninflammatory disorder of cervix uteri, unspecified
N89.0 - Mild vaginal dysplasia
N89.1 - Moderate vaginal dysplasia
N89.3 - Dysplasia of vagina, unspecified
N89.4 - Leukoplakia of vagina
N89.5 - Stricture and atresia of vagina
N89.7 - Hematocolpos
N89.8 - Other specified noninflammatory disorders of vagina
N89.9 - Noninflammatory disorder of vagina, unspecified
N92.4 - Excessive bleeding in the premenopausal period
N93.0 - Postcoital and contact bleeding
N93.8 - Other specified abnormal uterine and vaginal bleeding
N93.9 - Abnormal uterine and vaginal bleeding, unspecified
N94.2 - Vaginismus
N94.89 - Other specified conditions associated with female genital organs and menstrual cycle
N94.9 - Unspecified condition associated with female genital organs and menstrual cycle
N95.0 - Postmenopausal bleeding
N95.2 - Postmenopausal atrophic vaginitis
N99.2 - Postprocedural adhesions of vagina
O86.04 - Sepsis following an obstetrical procedure
Q51.6 - Embryonic cyst of cervix
Z12.4 - Encounter for screening for malignant neoplasm of cervix
Z85.41 - Personal history of malignant neoplasm of cervix uteri
Z85.42 - Personal history of malignant neoplasm of other parts of uterus
Related CPT Codes
CPT Codes
57415 - Complete Billing & Coding Guide for Manipulation Procedures on the Vagina
57420 - Endoscopy/Laparascopy Procedures on the Vagina
57421 - Endoscopy/Laparascopy Procedures on the Vagina
57423 - Endoscopy/Laparascopy Procedures on the Vagina
57460 - Endoscopy Procedures on the Cervix Uteri